BR100 Decreased By (-0.96%)
BR30 Decreased By (-1.08%)
KSE100 Decreased By (-0.88%)
KSE30 Decreased By (-0.81%)
AGHA 7.68 Decreased By ▼ -0.24 (-3.03%)
BECO 5.13 Decreased By ▼ -0.07 (-1.35%)
BML 57.49 Decreased By ▼ -1.76 (-2.97%)
BOP 33.09 Decreased By ▼ -0.59 (-1.75%)
CNERGY 10.14 Increased By ▲ 0.33 (3.36%)
CSIL 5.22 Decreased By ▼ -0.20 (-3.69%)
FCCL 52.81 Decreased By ▼ -0.71 (-1.33%)
FFL 16.28 Decreased By ▼ -0.40 (-2.4%)
FNEL 1.20 Decreased By ▼ -0.01 (-0.83%)
KEL 7.14 Decreased By ▼ -0.21 (-2.86%)
KOSM 5.55 Decreased By ▼ -0.06 (-1.07%)
LOTCHEM 28.50 Decreased By ▼ -0.61 (-2.1%)
MLCF 93.29 Decreased By ▼ -2.21 (-2.31%)
NBP 200.50 Decreased By ▼ -3.85 (-1.88%)
NCPL 55.99 Decreased By ▼ -2.25 (-3.86%)
NPL 66.13 Decreased By ▼ -1.66 (-2.45%)
OGDC 316.57 Decreased By ▼ -1.37 (-0.43%)
PACE 10.56 Decreased By ▼ -0.15 (-1.4%)
PAEL 40.97 Decreased By ▼ -0.86 (-2.06%)
PIBTL 16.26 Decreased By ▼ -0.24 (-1.45%)
PPL 218.97 Decreased By ▼ -0.77 (-0.35%)
PRL 47.12 Increased By ▲ 2.53 (5.67%)
PTC 69.74 Decreased By ▼ -1.03 (-1.46%)
SSGC 28.20 Decreased By ▼ -0.73 (-2.52%)
TBL 9.72 Decreased By ▼ -0.12 (-1.22%)
TELE 8.58 Decreased By ▼ -0.18 (-2.05%)
TPL 16.69 Increased By ▲ 0.24 (1.46%)
TPLP 12.20 Increased By ▲ 0.10 (0.83%)
TREET 22.32 Decreased By ▼ -0.48 (-2.11%)
TRG 59.02 Decreased By ▼ -1.01 (-1.68%)
اردو
Android App
Print Edition Dollar to PKR
Intl Oil Prices Iran-US war Petrol Prices Gold Rates Podcasts PSX Notices
World

German court suspends mRNA patent trial against BioNTech

Published Updated
Save
1 min
comment
By Reuters
Add BRecorder as a trusted
source on Google
Google Preferred Source

DUESSELDORF: A German court on Thursday suspended a patent trial against BioNTech over the use of mRNA technology in the COVID-19 vaccine developed by the German company together with its US partner Pfizer.

The Duesseldorf regional court said it needed further clarification and suspended the case, brought by BioNTech competitor CureVac, pending a decision by the federal patent court on a lawsuit filed by BioNTech.

Germany’s Scholz ‘not convinced’ about tariffs on Chinese EVs

It had asked the higher court to review the validity of CureVac’s intellectual property rights. A decision is expected in December.

Germany BioNTech Pfizer CureVac Covid 19 vaccine German court

Comments

Comments are closed for this article.

More Stories

Browse all stories